Benjamin Krämer - Concepedia

Author

Benjamin Krämer

Also Known As

B KRAMER, B Kramer, B Krämer, B. KRAMER, B. Kramer, B. Krämer, B. W. Kramer, BENJAMIN KRAMER, Benedikt Krämer, Benjamin Kramer

313

Publications

11.2K

Citations

H-Index

208

Concepts

All Affiliations

University of Bonn Jewish Hospital German Center for Infection Research Novartis (United States)Novartis (United Kingdom)

About

Benjamin Krämer is an author at University of Bonn specializing in medicine, physiology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	78	5.6K
2	Health Sciences	15	15	773
3	Engineering	2	2	32
4	Education	1	1	29
5	Humanities	1	1	18

Benjamin Krämer

125

Publications

10.2K

Citations

H-Index

Page 1

	Year	Citations
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment Jonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, Cell Covid-19 PandemicHematologyPathologyCovid-19 EpidemiologySevere Covid-19 Is	2020	1.6K
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia Carlos Salama, Jian Han, Linda Yau, New England Journal of Medicine	2020	1.3K
Swarm Learning for decentralized and confidential clinical machine learning Stefanie Warnat‐Herresthal, Hartmut Schultze, Krishnaprasad Lingadahalli Shastry, Nature	2021	788
Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease James F. Donohue, Charles Fogarty, Jan Lötvall, American Journal of Respiratory and Critical Care Medicine	2010	346
Efficacy of a new once-daily long-acting inhaled 2-agonist indacaterol versus twice-daily formoterol in COPD Ronald Dahl, Kian Fan Chung, Roland Buhl, Thorax	2010	272
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, Immunity Viral PersistenceMedicineViral PathogenesisImmunologyAntiviral Response	2021	249
Once-daily indacaterol<i>versus</i>twice-daily salmeterol for COPD: a placebo-controlled comparison Oliver Kornmann, Ronald Dahl, Stefano Centanni, European Respiratory Journal	2010	211
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study Michael Graf, D. Ecker, R. Horowski, Journal of Neural Transmission Neurodegenerative DiseasesAmyotrophic Lateral SclerosisPlacebo-controlled Double-blind StudyNeurological DisorderMedicine	2004	188
Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison Donald A. Mahler, Anthony D’Urzo, Eric Bateman, Thorax	2012	154
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma Bettina Langhans, Hans Dieter Nischalke, Benjamin Krämer, Cancer Immunology Immunotherapy Checkpoint InhibitionCancer ImmunosurveillanceHepatologyHepatocellular CarcinomaLiver Physiology	2019	150

Page 1